-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P0XQRWBRM4xk+fSL5gJPdGG4WVU5pfbw1PUKeaGWYdTkd9DvxEcxRO+Zzg4IyXfo S/9aJTJvnpgBEJnjcSb57g== 0001231919-07-000005.txt : 20070118 0001231919-07-000005.hdr.sgml : 20070118 20070118120025 ACCESSION NUMBER: 0001231919-07-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061226 FILED AS OF DATE: 20070118 DATE AS OF CHANGE: 20070118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GAROFALO STEPHEN A CENTRAL INDEX KEY: 0001053791 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 07536984 BUSINESS ADDRESS: STREET 1: 110 EAST 42ND STREET STREET 2: SUITE 1502 CITY: NEW YORK STATE: NY ZIP: 10017 MAIL ADDRESS: STREET 2: 110 EAST 42ND STREET SUITE 1502 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-12-26 0001037649 INTERLEUKIN GENETICS INC ILI 0001053791 GAROFALO STEPHEN A 6 TEAL COURT NEW CITY NY 10956-3156 0 0 1 0 Common Stock 2006-12-26 4 P 0 4830 5.50 A 3188297 I and Direct Common Stock 2006-12-28 4 P 0 1369 5.50 A 3189666 I and Direct Common Stock 2007-01-10 4 P 0 43801 5.50 A 3233467 I and Direct These shares were purchased by Lori Garofalo, the Reporting Person's spouse. (i) 2,368,500 of these shares are owned directly by the Reporting Person; (ii) 50,000 of these shares are owned by the Reporting Person's spouse; and (iii) 814,967 of these shares are owned by First Global Technology Corp. ("First Global"). The Reporting Person is the controlling stockholder of First Global and may be deemed to indirectly beneficially own those shares of the Issuer owned by First Global. The Reporting Person disclaims beneficial ownership of those shares of the Issuer owned by each of First Global and Lori Garofalo, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person owns those shares for purposes of Section 16. /s/Stephen Garofalo 2007-01-18 -----END PRIVACY-ENHANCED MESSAGE-----